Perrin MH, Donaldson CJ, Chen R, et al. (1994). „Cloning and functional expression of a rat brain corticotropin releasing factor (CRF) receptor.”. Endocrinology133 (6): 3058–61. DOI:10.1210/en.133.6.3058. PMID8243338.
Liaw CW, Lovenberg TW, Barry G, et al. (1996). „Cloning and characterization of the human corticotropin-releasing factor-2 receptor complementary deoxyribonucleic acid.”. Endocrinology137 (1): 72–7. DOI:10.1210/en.137.1.72. PMID8536644.
Donaldson CJ, Sutton SW, Perrin MH, et al. (1996). „Cloning and characterization of human urocortin.”. Endocrinology137 (5): 2167–70. DOI:10.1210/en.137.5.2167. PMID8612563.
Meyer AH, Ullmer C, Schmuck K, et al. (1997). „Localization of the human CRF2 receptor to 7p21-p15 by radiation hybrid mapping and FISH analysis.”. Genomics40 (1): 189–90. DOI:10.1006/geno.1996.4521. PMID9070940.
Valdenaire O, Giller T, Breu V, et al. (1997). „A new functional isoform of the human CRF2 receptor for corticotropin-releasing factor.”. Biochim. Biophys. Acta1352 (2): 129–32. PMID9199241.
Gottowik J, Goetschy V, Henriot S, et al. (1998). „Labelling of CRF1 and CRF2 receptors using the novel radioligand, [3H]-urocortin.”. Neuropharmacology36 (10): 1439–46. DOI:10.1016/S0028-3908(97)00098-1. PMID9423932.
Kostich WA, Chen A, Sperle K, Largent BL (1998). „Molecular identification and analysis of a novel human corticotropin-releasing factor (CRF) receptor: the CRF2gamma receptor.”. Mol. Endocrinol.12 (8): 1077–85. DOI:10.1210/me.12.8.1077. PMID9717834.
Willenberg HS, Bornstein SR, Hiroi N, et al. (2000). „Effects of a novel corticotropin-releasing-hormone receptor type I antagonist on human adrenal function.”. Mol. Psychiatry5 (2): 137–41. DOI:10.1038/sj.mp.4000720. PMID10822340.
Hsu SY, Hsueh AJ (2001). „Human stresscopin and stresscopin-related peptide are selective ligands for the type 2 corticotropin-releasing hormone receptor.”. Nat. Med.7 (5): 605–11. DOI:10.1038/87936. PMID11329063.
Wetzka B, Sehringer B, Schäfer WR, et al. (2004). „Expression patterns of CRH, CRH receptors, and CRH binding protein in human gestational tissue at term.”. Exp. Clin. Endocrinol. Diabetes111 (3): 154–61. DOI:10.1055/s-2003-39778. PMID12784189.
Hillier LW, Fulton RS, Fulton LA, et al. (2003). „The DNA sequence of human chromosome 7.”. Nature424 (6945): 157–64. DOI:10.1038/nature01782. PMID12853948.
Karteris E, Hillhouse EW, Grammatopoulos D (2004). „Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractility.”. Endocrinology145 (2): 890–900. DOI:10.1210/en.2003-1210. PMID14592950.
Seres J, Bornstein SR, Seres P, et al. (2004). „Corticotropin-releasing hormone system in human adipose tissue.”. J. Clin. Endocrinol. Metab.89 (2): 965–70. DOI:10.1210/jc.2003-031299. PMID14764822.
Brandenberger R, Wei H, Zhang S, et al. (2005). „Transcriptome characterization elucidates signaling networks that control human ES cell growth and differentiation.”. Nat. Biotechnol.22 (6): 707–16. DOI:10.1038/nbt971. PMID15146197.
Nanda SA, Roseboom PH, Nash GA, et al. (2004). „Characterization of the human corticotropin-releasing factor2(a) receptor promoter: regulation by glucocorticoids and the cyclic adenosine 5'-monophosphate pathway.”. Endocrinology145 (12): 5605–15. DOI:10.1210/en.2004-0907. PMID15331578.